⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 7, 2024Ophthalmology ScienceOpen Access

Prosthetic Visual Acuity with the PRIMA Subretinal Microchip in Patients with Atrophic Age-Related Macular Degeneration at 4 Years Follow-up

Mahiul M. K. Muqit Y. Le Mer Lisa C. Olmos de Koo Frank G. Holz José‐Alain Sahel Daniel Palanker

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the efficacy and safety of the PRIMA neurostimulation system with a subretinal microchip for improving visual acuity (VA) in patients with geographic atrophy (GA) due to age-related macular degeneration (AMD) at 48-months postimplantation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muqit et al. (2024) studied this question.

synapsesocial.com/papers/68e7542bb6db6435876cbeeb https://doi.org/10.1016/j.xops.2024.100510

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Surgical implantation and multimodal imaging of the PRIMA subretinal neurostimulation system in geographic atrophy: Safety and clinical insightsHuman Clinical Trial · 2026
2Enhancing Prosthetic Vision by Upgrade of a Subretinal Photovoltaic Implant in situ2024 · 1 citations
3Histological findings after subretinal implantation of the PRIMA photovoltaic array in patients with geographic atrophy due to AMDCase Report · 2026
4Patient Preferences for the PRIMA Retinal Prosthesis for Vision Restoration for Dry Age-Related Macular Degeneration: An International Survey StudyOriginal Research · 2026
5Simulation of prosthetic vision with the PRIMA system and enhancement of face representationOriginal Research · 2026